Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Receptor tyrosine-protein kinase erbB-2 (ErbB2/Her2) (C-Term) Peptide

ErbB2/Her2 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN5673015

Aperçu rapide pour Receptor tyrosine-protein kinase erbB-2 (ErbB2/Her2) (C-Term) Peptide (ABIN5673015)

Antigène

ErbB2/Her2 (Receptor tyrosine-protein kinase erbB-2 (ErbB2/Her2))

Origine

Humain

Source

  • 16
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Séquence

    DPTVPLPSET DGYVAPLTCS PQPEYVNQPD VRPQPPSPRE GPLPAARPAG

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti- ERBB2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    ErbB2/Her2 (Receptor tyrosine-protein kinase erbB-2 (ErbB2/Her2))

    Sujet

    This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized.

    Alias Symbols: NEU, NGL, HER2, TKR1, CD340, HER-2, MLN 19, HER-2/neu

    Protein Size: 645

    ID gène

    2064

    NCBI Accession

    NM_001005862, NP_001005862
Vous êtes ici:
Chat with us!